Safety Evaluation of Oral Sirolimus in the Treatment of Childhood Diseases: A Systematic Review

Background: Sirolimus, a mammalian target of rapamycin inhibitor, has been widely used in pediatric patients, but the safety of sirolimus in pediatric patients has not been well determined. Objective: The objective of this study was to systematically evaluate prospective studies reporting the safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zixin, Li, Yanan, Zhang, Guangyue, Yang, Kaiying, Qiu, Tong, Zhou, Jiangyuan, Gong, Xue, Ji, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497617/
https://www.ncbi.nlm.nih.gov/pubmed/36138604
http://dx.doi.org/10.3390/children9091295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497617/
https://www.ncbi.nlm.nih.gov/pubmed/36138604
http://dx.doi.org/10.3390/children9091295

Ejemplares similares